TouchNEUROLOGY recently spoke to world-renowned Alzheimer's disease (AD) researcher Bengt Winblad of Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden. Professor Winblad, a member of the TouchNeurology Editorial Board, spoke about emerging therapeutic targets for AD and the role of the FKBP51-Hsp90 complex in underlying pathophysiological processes.
You can watch the interview, filmed at the 6 Congress of the European Academy of Neurology (EAN) and 1 EAN Virtual Congress: https://bit.ly/37hpW4a
